U.S. equities rose at midday on optimism the new tariffs threatened by President Trump won't be as severe as initially believed.

We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

Robert F. Kennedy Jr. petitioned the F.D.A. to revoke authorization of the shots at a time when they were in high demand and ...

Albert Bourla and other healthcare CEOs talked about the efficacy of vaccines and how public health could take a big turn for ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

Four years from now, what might we be saying about what we just lived through? The possibilities seem endless.

Moderna MRNA provided an update on its financial outlook and pipeline progress at the J.P. Morgan Healthcare Conference. At ...

At the healthcare conference, Moderna lowered expected 2025 revenue to the range of $1.5 billion to $2.5 billion -- down from ...

And regular polling carried out by YouGov suggests adults are increasingly likely to say that vaccines have harmful side ...

Moderna is down 80% from its 52-week high as revenues continue to fall and the new RSV vaccine has performed poorly. Read my ...

Rare instances of vaccine side effects must not be used to “undermine the vital public health role that vaccination plays in ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...